Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/2/09 → 2/1/15 |
Funding
- Novartis Vaccines and Diagnostics, Inc: $25,004.00
Protocol No. V59P13E1: A Phase 3, Open-Label,Multi-Center Study to Evaluate the Persistence of Novartis MenACWY Antibody Response in Adolescents who Have Previously received either Novartis MenACWY Conjugate Vaccine or Menactra
- Rupp, Richard (PI)
Project: Research project